Urologic Cancer Program

Program Overview

At Penn Medicine's Abramson Cancer Center, our urologic cancer clinicians and researchers have led the way for years in the diagnosis and treatment of urologic cancers. By putting our experience to work, we offer the best possible treatment outcomes.

If you have been diagnosed with a urologic cancer, you'll want the best team of experts. Our Penn experts have worked together for years to offer high-quality medical care that leads to faster recovery time, and the best chance of being cured. U.S. News & World Report ranks Penn's urology program the among the best in the nation.

Your urologic cancer team includes:

  • Specialists in urology, medical oncology, surgical oncology, radiation oncology, radiology and pathology.
  • Nurses, nurse practitioners, and physician assistants with advanced training and experience in urologic cancer.
  • Oncology Navigators who are experts in navigating complex health care situations and act as a consistent point of contact and a reliable source for support.
  • Cancer counselors who work exclusively with cancer patients and their families.
  • Registered dietitians who specialize in cancer nutrition and provide information based on sound nutritional therapies.

Conditions Treated by the Urologic Cancer Program

Like other forms of cancer, the earlier urological cancer is detected, the greater the chance a successful treatment can be implemented.

We provide diagnosis and treatment for:

  • Bladder cancer - Along with minimally invasive bladder-sparing treatments, Penn urologists have experience in creating a new bladder for patients in whom the bladder is removed.
  • Kidney cancer - Penn urologists have a wealth of experience in managing kidney cancer, with an emphasis on sparing the kidney whenever possible.
  • Penile cancer - We have care providers specially trained in the diagnosis and management of these uncommon tumors.
  • Prostate cancer - Prostate cancer is among the most common cancers in American men. All of the latest advances in the treatment of prostate cancer are available at Penn.
  • Testicular cancer - In younger men (ages 15 to 45), testicular cancer is the most common form of urologic cancer. Penn urologists are experienced in the latest techniques and protocols for treating this serious disease.

Why Penn’s Urologic Cancer Program is Different

  • We offer the region's most advanced diagnostic testing, treatments, and technologies. Our urologists are world renowned in cutting-edge surgical techniques, including nerve-sparring and robotically-assisted prostatectomy.
  • We perform more prostatectomies, as well as transurethral and testicular procedures, than any other Greater Philadelphia hospital.
  • We offer an innovative and highly respected Developmental Therapeutics Program, which has launched phase I and phase II clinical trials for patients with androgen-independent prostate cancer.
  • We provide personalized attention from a multidisciplinary team who is nationally and internationally recognized for treating all types of urologic cancers.
  • We have a reputation for sensitivity and responsiveness.

Treatments and Services Offered by the Urologic Cancer Program